THE Therapeutic Goods Administration (TGA) is seeking comments from interested parties on an update to guidance relating to the export of medicines and medical devices from Australia.
Potential changes proposed would allow documents to be provided in electronic form rather than as a hard copy, and whether the TGA should provide traceable postage for all hard copy certificates.
The consultation document is now available at tga.gov.au, with responses due by 03 Feb.
As well as exporting for commercial purposes it covers guidance for sending medicines abroad for personal use, plus export of unapproved drugs for use in clinical trials.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 Dec 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Dec 19